Lyon Street Capital, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Lyon Street Capital, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,769,000
-72.8%
364,697
-65.0%
1.10%
-52.4%
Q2 2018$6,504,000
-46.2%
1,040,661
-28.5%
2.31%
-40.6%
Q1 2018$12,082,000
+51.2%
1,455,614
+85.8%
3.89%
+46.0%
Q4 2017$7,993,000
+287.4%
783,583
+247.5%
2.66%
+235.2%
Q3 2017$2,063,000225,4660.80%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
DSC Advisors, L.P. 693,582$4,057,0002.30%
DAFNA Capital Management LLC 38,873$227,0000.20%
FALCON POINT CAPITAL, LLC 85,588$501,0000.07%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 229,166$1,341,0000.06%
Cormorant Asset Management, LP 50,613$296,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 14,587$85,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$468,0000.01%
MILLENNIUM MANAGEMENT LLC 296,175$1,733,0000.00%
FRANKLIN RESOURCES INC 1,315,500$7,696,0000.00%
COLUMBUS CIRCLE INVESTORS 42,304$247,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders